Compared to earlier Phase III study, women’s adherence to monthly HIV prevention ring is higher and data suggest infection rates are lower.
New Prevention Technologies
First clinical trial of IPM’s dual-purpose vaginal ring builds on promising microbicide technology to address overlapping threats to women’s sexual and reproductive health